title: How does a drug get to phase III trials?
authors.forename: T
authors.initials: T
authors.lastname: Reynolds
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval / Q000379:methods*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational